Increasing Efficiency In Clinical Trials With Flexible IRT

Join endpoint Clinical's director of solutions and strategic partnerships, Alyssa Williams, as she reveals the benefits of flexible IRT design and considerations for building an optimal IRT solution to avoid delays and increase efficiency. 

• In this webinar, you will learn how to:Implement and manage flexible patient enrollment.
• Maximize inventory functionality to ensure supply efficiency and availability.
• Identify and implement study-specific functionality.
• Successfully employ integrations to ensure data sharing and limit reconciliation.
• Effectively partner with your IRT provider to address any scenario.

The Use of Digital Health Tools in Oncology Clinical Trials

Discover how stakeholders can move past the hurdles that have prevented the rapid uptake of digital health tools that could transform oncology clinical trials and patient care. Download your free insights from a recent roundtable presented by Medtech Insight, in partnership with Biofourmis.

Don’t miss your opportunity to explore expert perspectives on:

• The impact of digital tools on providers and facilities
• Researchers’ considerations
• The importance of regulator input
• Stakeholder collaboration as a means to facilitate innovation
• The potential of AI use in research and approvals

Are Milestone-Based Approaches The Future Of Biopharma And CDMO Partnerships?

Traditionally, biopharma sponsors have used contract development and manufacturing organizations (CDMOs) either for a specific task or for entire-project support. But a milestone-based approach to the relationship offers benefits not seen in these traditional models.

The Need To Re-Establish CDMO Relationships In A Changing Landscape

Explore the use of digital technology in oncology clinical trials and understand:The impact of digital tools on providers and facilities

• Researcher considerations
• The importance of regulators in fostering digital health innovation
• Drug development and the digital health technology ecosystem
• The promises and pitfalls of artificial intelligence for drug research and approvals

What Makes a CDMO Truly Flexible in Biologics Drug Development?

You’ll explore:

• The unique processes of developing biologics
• What true flexibility really means
• The key to reaping the benefits of a flexible CDMO
• The importance of working with a CDMO offering diverse services and facilities

When To Scrap Your Process And Go To A CDMO Platform

Explore the use of digital technology in oncology clinical trials and understand:The impact of digital tools on providers and facilities

• Researcher considerations
• The importance of regulators in fostering digital health innovation
• Drug development and the digital health technology ecosystem
• The promises and pitfalls of artificial intelligence for drug research and approvals

Why Should Biopharma Consider An End-to-End CDMO Partnership?

Download now to explore:

• How to mitigate the risks of tech transfer and support
• Tips for maintaining flexibility and efficient quality management
• How to pick the right CDMO partner
• How to implement a CDMO partnership at the right time

Don’t miss an analysis of the benefits that an end-to-end CDMO partner can bring to your biopharma drug development programs.

Upgrading Pharmaceutical Safety Systems: Latest Argus Considerations

Experts will discuss:

• The current pharmaceutical regulatory landscape and to what degree the latest Argus version supports it
• Whether the out-of-the-box functions of Argus 8.4 and 8.4.1 meet business’ needs or require additional configuration or customization
• What features can be expected in future releases of pharmaceutical safety systems, specifically Argus 8.4.2

New Pharmaceutical Safety Regulations For 2023 and Beyond

Experts will discuss:

• What new pharmacovigilance regulations you should be keeping an eye on
• The major elements of the product harmonization initiative IDMP and what they mean for compliance
• How the evolution of codelist harmonization impacts Medical Device Reporting
• What is in store for Pharmaceutical Vigilance Obligations

Solutions from pre-clinical to commercial

Don’t miss the important insights in “Transforming Imaging Data Into Actionable Predictions With The Power Of AI” from Citeline’s In Vivo, presented in partnership with Quibim.